Helicos Shares Hit $1 for First Time in Six Months | GenomeWeb

NEW YORK (GenomeWeb News) – Following yesterday's announcement that it had sold one of its Helicos Genetic Analysis Systems to an undisclosed biotechnology company, shares of Helicos BioSciences today traded above $1 per share for the first time in six months.

The Cambridge, Mass.-based firm thus far has announced instrument placements or orders at Stanford University, the Broad Institute, the Dana-Farber Cancer Institute, and the University of Maryland. But this new sale would be the first that it has disclosed for a commercial entity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.